| Literature DB >> 26611872 |
Paula Alves Monteiro1,2,3, Kong Y Chen4, Fabio Santos Lira5, Bruna Thamyres Cicotti Saraiva6, Barbara Moura Mello Antunes5, Eduardo Zapaterra Campos5, Ismael Forte Freitas6.
Abstract
BACKGROUND: The prevalence of obesity in pediatric population is increasing at an accelerated rate in many countries, and has become a major public health concern. Physical activity, particularly exercise training, remains to be a cornerstone of pediatric obesity interventions. The purpose of our current randomized intervention trial was to compare the effects of two types of training matched for training volume, aerobic and concurrent, on body composition and metabolic profile in obese adolescents. Thus the aim of the study was compare the effects of two types of training matched for training volume, aerobic and concurrent, on body composition and metabolic profile in obese adolescents.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26611872 PMCID: PMC4660803 DOI: 10.1186/s12944-015-0152-9
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Intensity of aerobic training
| N° of weeks | Intensity | |
|---|---|---|
| Stage 1 | 2 | 13 to 14 of Borg scale |
| Stage 2 | 2 | 65 % of VO2 peak |
| Stage 3 | 4 | 70 % of VO2 peak |
| Stage 4 | 4 | 75 % of VO2 peak |
| Stage 5 | 4 | 80 % of VO2 peak |
| Stage 6 | 4 | 85 % of VO2 peak |
The resistance training intensity
| N° of weeks | Intensity | N° of sets | Repetitions/set | |
|---|---|---|---|---|
| Stage 1 | 2 | Minimum loads | 1 | 20 |
| Stage 2 | 2 | 55 % RM | 1 | 20 |
| Stage 3 | 4 | 60 % RM | 1 | 20 |
| Stage 4 | 4 | 65 % RM | 1 | 20 |
| Stage 5 | 2 | 70 % RM | 2 | 10 |
| 2 | 2 | 12 | ||
| Stage 6 | 2 | 75 % RM | 2 | 12 |
| 2 | 2 | 15 |
Fig. 1Control, aerobic and concurrent training groups in trial flow diagram
Fig. 2Effect of training in the percentage of body fat after 20 weeks of intervention in obese adolescents
Baseline and end measurements in obese adolescents, expressed in mean (standard deviation)
| Control ( | Aerobic Training ( | Concurrent Training ( | ||||
|---|---|---|---|---|---|---|
| Baseline | End | Baseline | End | Baseline | End | |
| Age (years) | 11.04(1.90) | 11.32(1.90) | 11.00(1.02) | 11.42(1.02) | 11.03(1.34) | 11.42(1.34) |
| Body mass (kg) | 77.60(16.97) | 80.20(17.09)b | 74.08(12.13) | 73.02(11.43)a | 86.67(12.98) | 86.46(11.32)a |
| BMI (kg/m2) | 30.95(3.42) | 32.04(34.48)a | 30.15(2.90) | 28.71(3.02)ab | 33.17(4.7) | 32.36(4.46)a |
| Sex | 8 girls 8 boys | 8 girls 10 boys | 5 girls 9 boys | |||
| Body Composition | ||||||
|
| 47.77(3.57) | 47.98(3.94)b | 46.71(3.28) | 43.12(3.74)a | 48.06(3.89) | 45.21(4.53)a |
|
| 36.94(7.44) | 38.16(6.80) | 34.73(7.04) | 31.61(6.50) | 42.02(9.76) | 39.41(8.74) |
|
| 37.89(9.33) | 39.59(10.98) | 36.97(5.58) | 38.83(5.66) | 42.07(4.04) | 44.42(3.91) |
|
| 55.58(2.80) | 55.96(2.56)b | 53.82(4.14) | 49.83(4.41)a | 56.07(2.78) | 52.56(3.32)a |
|
| 93(9.33) | 95.52(11.80)b | 89.77(5.81) | 85.52(6.08)a | 97.29(10.65) | 93.52(7.55)b |
|
| 3.57(1.13) | 3.58(1.06)b | 3.35(0.98) | 2.53(0.99)a | 4.11(1.70) | 4.05(1.67)ab |
|
| 3.15(0.63) | 2.96(0.58) | 2.72(0.64) | 2.58(0.72) | 2.91(0.97) | 3.04(0.62) |
| Lipids | ||||||
|
| 150.60(28.63) | 130.19(33.14) | 142.12(28.42) | 112.52(25.20) | 150.64(54.97) | 110.38(18.85) |
|
| 134.86(55.88) | 154.30(46.41)b | 153.13(28.07) | 121.21(34.86)a | 144.02(36.40) | 117.74(26.10)a |
|
| 42.86(8.67) | 36.33(11.88)b | 34.85(3.70) | 37.91(10.21)ab | 36.90(3.06) | 42.39(12.24)a |
|
| 79.46(23.95) | 69.06(27.57) | 76.42(29.31) | 50.36(27.79) | 74.51(18.40) | 40.60(20.77) |
|
| 28.26(12.99) | 30.86(9.28)b | 30.62(5.62) | 24.24(6.97)a | 28.80(7.28) | 23.54(5.22)a |
|
| 0.97(013) | 1.00(0.105) | 1.01(0.12) | 0.93(0.075) | 1.01(0.067) | 0.94(0.094) |
%BF Percentage of body fat, FFM Fat free mass, %AF Percentage android fat, IAAT Intra-abdominal adiposity tissue, SAT Subcutaneous adiposity tissue, CHO Total cholesterol, very low density lipoprotein, TG triacylglycerol, HDL high density lipoprotein, LDL low density lipoprotein, VLDL very low density lipoprotein;. Lowercase letters difference between groups p <0.05 by ANOVA (ITT analyses). a, b means that the changes between baseline and end measures were different from each other, and ab means that it is similar to either a and b
Summary of independent associations between training types, baseline characteristics and the changes of body composition and metabolic profiles by multiple linear regression analysis.
| Unstandardized coefficients | Standardized Coefficients | |||||
|---|---|---|---|---|---|---|
| Changes (end-baseline)/predictors | B | Std. error | Adjusted R square | t | Beta |
|
| % Body Fat | ||||||
| Type of training1 | −1.825 | 0.442 | 0.267 | −4.129 | −0.53 | <0.001 |
| Constant | −0.180 | 0.597 | −0.301 | 0.765 | ||
| Hepatic steatosis2 | ||||||
| Baseline hepatic steatosis | −0.507 | 0.127 | 0.185 | −3.999 | −0.560 | <0.001 |
| Baseline IAAT3 | 0.107 | 0.046 | 0.265 | 2.336 | 0.327 | 0.025 |
| Constant | −0.215 | 0.169 | −1.274 | 0.210 | ||
| VLDL4 | ||||||
| Type of training | −5.297 | 1.562 | 0.359 | −3.391 | −0.445 | 0.002 |
| Baseline VLDL | −0.511 | 0.169 | 0.477 | −3.028 | −0.397 | 0.005 |
| Constant | 18.18 | 4.467 | 4.070 | <0.001 | ||
1Type of training: 0= control group, 1= concurrent training, 2= aerobic training; 2Degree Hepatic steatosis: 0= ausence of hepatic steatosis, 1= presence of hepatic steatosis; 3Intra-abdominal adiposity tissue (IAAT) (cm); 4Very low density lipoproteins (VLDL) (mg/dl); 5Variables did not reach statistical significance: age, gender, baseline BMI, baseline % body fat, baseline growth velocity